Bank of Baroda reported a 5.6% year-on-year rise in standalone net profit for Q3FY25, reaching ₹4,837 crore, compared to ₹4,579 crore in the same period last year.

Revenue from operations rose by 16.81 per cent to Rs 4,443.56 crore during the quarter under review. It was at Rs 3,803.92 crore in the year-ago period.

The company's revenue from operations jumped 39.51 per cent to Rs 7,286.88 crore in Q3 FY25 from Rs 5,223.08 crore in the corresponding period last year.

Ajanta Pharma on Thursday said its consolidated profit after tax increased by 11 per cent on-year to Rs 233 crore for the third quarter ended December 31, 2024.

Results: Profit fell short of ET Now's estimate of Rs 6,791 crore, while revenue rose 3% YoY to Rs 1.13 lakh crore. Consolidated EBITDA rose to Rs 15,500 crore, driven by easing supply challenges. CV revenues fell 8.